Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Assets (2020 - 2025)

Celularity (CELU) has disclosed Assets for 6 consecutive years, with $107.3 million as the latest value for Q4 2025.

  • For Q4 2025, Assets fell 19.11% year-over-year to $107.3 million; the TTM value through Dec 2025 reached $107.3 million, down 19.11%, while the annual FY2025 figure was $107.3 million, 19.11% down from the prior year.
  • Assets hit $107.3 million in Q4 2025 for Celularity, down from $114.2 million in the prior quarter.
  • Across five years, Assets topped out at $448.3 million in Q3 2021 and bottomed at $107.3 million in Q4 2025.
  • Average Assets over 5 years is $245.3 million, with a median of $150.5 million recorded in 2023.
  • Year-over-year, Assets surged 234.33% in 2022 and then tumbled 64.12% in 2023.
  • Celularity's Assets stood at $414.1 million in 2021, then fell by 3.15% to $401.1 million in 2022, then crashed by 64.12% to $143.9 million in 2023, then dropped by 7.79% to $132.7 million in 2024, then fell by 19.11% to $107.3 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $107.3 million, $114.2 million, and $120.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.